iShares MSCI Australia ETF vs Humana Inc — how do they compare? iShares MSCI Australia ETF trades at $29.99, while Humana Inc trades at $379.69 (market cap $44.77B). The key difference: Humana Inc pays a 0.95% dividend while iShares MSCI Australia ETF pays none. Which is the better fit depends on your goals.
| EWA | HUM | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $30.41 | $409.42 |
52-Week Low | $24.95 | $163.67 |
Market Cap | — | $44.77B |
Enterprise Value | — | $52.12B |
Dividend Yield | — | 0.95% |
Signals from Pluang's Aura AI — not financial advice
EWA trades at $29.985, down 0.22% on the day, with a bullish technical signal from moving averages and strong trend strength indicated by ADX readings. The stock shows neutral momentum oscillators, and support/resistance levels are consolidated around $30. A dividend of $0.40 is scheduled for June 2026, providing income potential.
Outlook remains cautiously optimistic given technical strength, but fundamental data is unavailable for valuation assessment. Risks include reliance on Australian economic conditions and sector-specific headwinds. Investors should seek updated financials for a complete view amid mixed sentiment.
Humana (HUM) trades at $385.47, up 0.12% on the day, with a bullish technical signal and strong earnings beats in recent quarters. Revenue growth remains robust, reaching $129.66B in 2025, though net income margins have compressed to 0.88%. Recent news highlights leadership changes and Medicaid contract wins, while analyst consensus leans Hold with a $409.93 price target.
Outlook is mixed: Medicare Advantage margin expansion plans and cost controls offer upside, but regulatory pressures and margin erosion pose risks. The stock presents a cautious opportunity for investors betting on operational turnaround, with technical support near $382.
Trailing returns across standard periods
EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →